186 filings
20-F
2023 FY
IMAB
I-Mab
Annual report (foreign)
30 Apr 24
7:01am
6-K
IMAB
I-Mab
15 Apr 24
Current report (foreign)
4:29pm
6-K
IMAB
I-Mab
2 Apr 24
I-Mab Announces Closing of the Divestiture of Business Operations in China
4:57pm
6-K
IMAB
I-Mab
1 Apr 24
Current report (foreign)
9:01am
144
Feng Gigi Qi
15 Mar 24
Notice of proposed sale of securities
6:33am
6-K
IMAB
I-Mab
15 Mar 24
I-Mab Reports Full Year 2023 Financial Results and Business Update
6:02am
SC 13G/A
IMAB
I-Mab
13 Feb 24
I-Mab / GIC Private ownership change
11:26am
SC 13G/A
Jingwu Zhang Zang
9 Feb 24
I-Mab / Zang Jingwu Zhang ownership change
4:01pm
144
IMAB
I-Mab
8 Feb 24
Notice of proposed sale of securities
6:07am
6-K
IMAB
I-Mab
7 Feb 24
I-Mab Signs Agreement
6:52am
6-K
IMAB
I-Mab
6 Feb 24
Current report (foreign)
6:34am
144
Zhu Andrew
5 Jan 24
Notice of proposed sale of securities
6:21am
144
Li Richard Cheng
29 Dec 23
Notice of proposed sale of securities
6:12am
144
IMAB
I-Mab
26 Dec 23
Notice of proposed sale of securities
6:22am
SC 13D
T Investment Ltd
1 Dec 23
I-Mab / T Investment ownership change
2:41pm
144
Li Richard Cheng
16 Nov 23
Notice of proposed sale of securities
6:43am
144
Everest Medicines Ltd
10 Oct 23
Notice of proposed sale of securities
11:04am
6-K
IMAB
I-Mab
10 Oct 23
I-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1BB Bispecific Antibody TJ-L14B/ABL503
8:24am
144
Tang Weimin
29 Sep 23
Notice of proposed sale of securities
6:15am
6-K
IMAB
I-Mab
22 Sep 23
Current report (foreign)
4:01pm